Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 3:13 pm Sale | 13G | PRINCIPIA BIOPHARMA INC PRNB | Cormorant Asset Management LP | 0 0% | -1,990,922 (Position Closed) | View |
| 2020-09-30 9:00 pm Sale | 13D | PRINCIPIA BIOPHARMA INC PRNB | GSK plc GSK | 0 0% | -3,042,193 (Position Closed) | View |
| 2020-09-10 10:03 am Sale | 13G | PRINCIPIA BIOPHARMA INC PRNB | FMR LLC | 352,167 1.059% | -4,565,765 (-92.84%) | View |
| 2020-08-25 12:32 pm Unchanged | 13D | PRINCIPIA BIOPHARMA INC PRNB | BIOTECHNOLOGY VALUE FUND L P | 5,231,900 15.7% | 0 (Unchanged) | View |
| 2020-08-19 1:49 pm Purchase | 13G | PRINCIPIA BIOPHARMA INC PRNB | BIOTECHNOLOGY VALUE FUND L P | 5,231,900 15.7% | 3,515,166 (+204.76%) | View |
| 2020-02-14 4:39 pm Purchase | 13D | PRINCIPIA BIOPHARMA INC PRNB | GSK plc GSK | 3,042,193 9.3% | 387,857 (+14.61%) | View |
| 2020-02-14 4:25 pm Purchase | 13G | PRINCIPIA BIOPHARMA INC PRNB | Redmile Group LLC | 2,722,388 8.3% | 2,722,388 (New Position) | View |
| 2020-02-14 4:14 pm Sale | 13G | PRINCIPIA BIOPHARMA INC PRNB | BAKER BROS. ADVISORS LP | 1,808,684 5.5% | -61 (-0.00%) | View |
| 2020-02-14 4:02 pm Purchase | 13G | PRINCIPIA BIOPHARMA INC PRNB | Cormorant Asset Management LP | 1,990,922 6.07% | 516,560 (+35.04%) | View |
| 2020-02-14 3:26 pm Purchase | 13G | PRINCIPIA BIOPHARMA INC PRNB | BIOTECHNOLOGY VALUE FUND L P | 1,716,734 5.2% | 79,884 (+4.88%) | View |
| 2020-02-13 1:22 pm Sale | 13G | PRINCIPIA BIOPHARMA INC PRNB | Sofinnova Venture Partners VIII L.P. | 1,438,196 4.4% | -620,950 (-30.16%) | View |
| 2020-02-12 5:38 pm Sale | 13G | PRINCIPIA BIOPHARMA INC PRNB | New Leaf Ventures II L.P. | 943,248 2.9% | -1,714,500 (-64.51%) | View |
| 2020-02-10 9:01 pm Sale | 13G | PRINCIPIA BIOPHARMA INC PRNB | MORGENTHALER VENTURE PARTNERS IX LP | 0 0% | -2,223,748 (Position Closed) | View |
| 2020-02-07 11:28 am Purchase | 13G | PRINCIPIA BIOPHARMA INC PRNB | FMR LLC | 4,917,932 14.999% | 1,338,145 (+37.38%) | View |
| 2020-02-07 08:45 am Purchase | 13G | PRINCIPIA BIOPHARMA INC PRNB | BlackRock Inc. BLK | 1,870,957 5.7% | 1,870,957 (New Position) | View |
| 2020-01-28 11:02 am Purchase | 13G | PRINCIPIA BIOPHARMA INC PRNB | WELLINGTON MANAGEMENT GROUP LLP | 2,072,070 6.32% | 2,072,070 (New Position) | View |
| 2019-12-13 4:32 pm Sale | 13G | PRINCIPIA BIOPHARMA INC PRNB | ORBIMED ADVISORS LLC | 288,119 0.9% | -2,346,217 (-89.06%) | View |
| 2019-10-28 5:25 pm Purchase | 13G | PRINCIPIA BIOPHARMA INC PRNB | BIOTECHNOLOGY VALUE FUND L P | 1,636,850 5% | 1,636,850 (New Position) | View |